This study has demonstrated that the propofol requirement for a LOC and the achievement of a BIS of 40 is higher in patients undergoing transsphenoidal surgery for a growth hormone-secreting pituitary tumor than in their counterparts with a nonfunctioning pituitary tumor. This evidence concerns the gene GH1 and pituitary tumor.